These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38405912)

  • 1. TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental inflammatory bowel disease.
    Menghini P; Butto L; Gomez-Nguyen A; Aladyshkina N; Buela KA; Osme A; Chan R; Bamias G; Pizarro TT; Cominelli F
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
    Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
    Front Immunol; 2018; 9():362. PubMed ID: 29545797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
    Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD.
    Bamias G; Menghini P; Pizarro TT; Cominelli F
    Gut; 2024 Sep; ():. PubMed ID: 39266053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion.
    Wang D; Li H; Duan YY; Han F; Luo YX; Wu MY; Yang MY; Zhan RR; Song J; Zhang H; Zhang XL
    Life Sci; 2019 Aug; 231():116536. PubMed ID: 31176785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma.
    Niese ML; Pajulas AL; Rostron CR; Cheung CCL; Krishnan MS; Zhang J; Cannon AM; Kaplan MH
    Mucosal Immunol; 2024 Aug; 17(4):537-553. PubMed ID: 38493956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
    Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
    J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation (Review).
    Yu Y; Jiang P; Sun P; Su N; Lin F
    Exp Ther Med; 2021 Jul; 22(1):693. PubMed ID: 33986858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease.
    Furfaro F; Alfarone L; Gilardi D; Correale C; Allocca M; Fiorino G; Argollo M; Zilli A; Zacharopoulou E; Loy L; Roda G; Danese S
    Curr Drug Targets; 2021; 22(7):760-769. PubMed ID: 33475057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.